13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001795097
Total reported value
$544.2M
$544.2M
60 檔
40.2%
According to the latest 13F quarterly dataset, Privium Fund Management B.V. managed an equity portfolio of $544.2M at the end of Q1 2026, spanning 60 distinct U.S. exchange-listed positions.
In Q1 2026, Privium Fund Management B.V. displayed an active expansion posture, initiating 7 new positions and adding to 24 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TSLA | Tesla Inc | Stock-Consumer Disc | 17.18% | +0.44% | -2.84% | |
| 2 | SHOP | Shopify Inc - Class A | Stock-Tech | 10.05% | -2.29% | -0.73% | |
| 3 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 6.76% | -2.12% | -1.47% | |
| 4 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 6.09% | -1.80% | — | |
| 5 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 5.42% | +0.71% | +3.31% | |
| 6 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 4.79% | -1.28% | -7.85% | |
| 7 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 4.53% | +0.13% | +20.43% | |
| 8 | LMND | Lemonade Inc | Stock-Financials | 3.33% | -0.10% | +2.82% | |
| 9 | NVDA | Nvidia CORP | Stock-Tech | 2.94% | +0.04% | — | |
| 10 | COIN | Coinbase Global Inc -class A | Stock-Financials | 2.87% | -2.87% | EXIT | |
| 11 | AMD | Advanced Micro Devices | Stock-Tech | 2.63% | +3.99% | +3.33% | |
| 12 | ASTS | Ast Spacemobile Inc | Stock-Tech | 2.50% | -0.13% | — | |
| 13 | SE | Sea Ltd-adr | Stock-Comm Services | 2.38% | -2.38% | EXIT | |
| 14 | IREN | IREN Limited | Stock-Other | 2.28% | +0.58% | +14.34% | |
| 15 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 2.07% | -0.27% | +3.25% | |
| 16 | ESPR | Esperion Therapeutics Inc | Stock-Other | 1.88% | -1.88% | EXIT | |
| 17 | ✓ | Proqr Therapeutics N.v. | Stock-Other | 1.84% | +0.05% | +2.04% | |
| 18 | BIIB | Biogen Inc | Stock-Healthcare | 1.67% | +0.25% | -40.39% | |
| 19 | QURE | uniQure N.V. | Stock-Other | 1.66% | +1.12% | +16.88% | |
| 20 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.59% | +0.49% | +2.04% | |
| 21 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 1.57% | +0.35% | +4.90% | |
| 22 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 1.09% | -0.30% | — | |
| 23 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.06% | -0.20% | +21.38% | |
| 24 | DNLI | Denali Therapeutics Inc | Stock-Other | 1.02% | +0.07% | — | |
| 25 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.89% | +0.53% | +10.95% | |
| 26 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 0.84% | -0.21% | — | |
| 27 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.71% | -0.12% | — | |
| 28 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.60% | +0.16% | -8.22% | |
| 29 | ABEV | Ambev Sa-adr | Stock-Consumer Staples | 0.58% | -0.12% | -10.78% | |
| 30 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.52% | -0.09% | — | |
| 31 | BNTX | Biontech Se-adr | Stock-Other | 0.50% | +0.01% | -18.92% | |
| 32 | ✓ | Engene Holdings Inc | Stock-Other | 0.50% | -0.50% | EXIT | |
| 33 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.42% | +0.03% | — | |
| 34 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.38% | +0.11% | +6.06% | |
| 35 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.36% | -0.10% | +24.87% | |
| 36 | STOK | Stoke Therapeutics Inc | Stock-Other | 0.34% | -0.34% | EXIT | |
| 37 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.33% | -0.11% | -18.93% | |
| 38 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.32% | +0.12% | -10.51% | |
| 39 | MRNA | Moderna Inc | Stock-Healthcare | 0.32% | +0.07% | -39.52% | |
| 40 | PFE | Pfizer Inc | Stock-Healthcare | 0.31% | -0.31% | EXIT | |
| 41 | LXEO | Lexeo Therapeutics Inc | Stock-Other | 0.24% | -0.11% | +6.47% | |
| 42 | RNAC | Cartesian Therapeutics Inc | Stock-Other | 0.23% | +0.06% | +3.83% | |
| 43 | MOH | Molina Healthcare Inc | Stock-Healthcare | 0.23% | -0.10% | — | |
| 44 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.21% | +0.24% | +6.98% | |
| 45 | SLB | Slb LTD | Stock-Energy | 0.20% | -0.20% | EXIT | |
| 46 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 0.18% | -0.03% | +42.32% | |
| 47 | HIMS | Hims & Hers Health Inc | Stock-Healthcare | 0.17% | +0.34% | — | |
| 48 | TSHA | Taysha Gene Therapies Inc | Stock-Other | 0.17% | +0.08% | +10.31% | |
| 49 | NOV | Nov Inc | Stock-Energy | 0.16% | -0.02% | -20.89% | |
| 50 | RIG | Transocean Ltd. | Stock-Energy | 0.15% | -0.02% | -23.64% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IONS | Ionis Pharmaceuticals Inc | +1% | +20.43% | Add |
| 2 | ASTS | Ast Spacemobile Inc | +0.6% | — | Unchanged |
| 3 | IREN | IREN Limited | +0.3% | +14.34% | Add |
| 4 | AMZN | Amazon.com Inc | +0.3% | +3.31% | Add |
| 5 | VRTX | Vertex Pharmaceuticals Inc | +0.3% | +21.38% | Add |
| 6 | AMD | Advanced Micro Devices | +0.3% | +3.33% | Add |
| 7 | NVDA | Nvidia CORP | +0.2% | — | Unchanged |
| 8 | AXSM | Axsome Therapeutics Inc | +0.2% | +3.25% | Add |
| 9 | PFE | Pfizer Inc | +0.1% | +39.55% | Add |
| 10 | ABEV | Ambev Sa-adr | +0.1% | -10.78% | Trim |
| 11 | MGTX | MeiraGTx Holdings plc | +0.1% | +6.06% | Add |
| 12 | ZLAB | Zai Lab Ltd-adr | +0.1% | — | Unchanged |
| 13 | LMND | Lemonade Inc | +0.1% | +2.82% | Add |
| 14 | RARE | Ultragenyx Pharmaceutical In | +0.1% | +2.04% | Add |
| 15 | RCKT | Rocket Pharmaceuticals Inc | +0.1% | +42.32% | Add |
| 16 | TDW | Tidewater Inc | +0.1% | — | Unchanged |
| 17 | KRYS | Krystal Biotech Inc | +0.1% | -8.22% | Trim |
| 18 | MRNA | Moderna Inc | +0.1% | -39.52% | Trim |
| 19 | RIG | Transocean Ltd. | 0% | -23.64% | Trim |
| 20 | SRPT | Sarepta Therapeutics Inc | 0% | +6.98% | Add |
| 21 | FDMT | 4d Molecular Therapeutics In | 0% | -18.93% | Trim |
| 22 | FATE | Fate Therapeutics Inc | 0% | +12.25% | Add |
| 23 | VYGR | Voyager Therapeutics Inc | 0% | +26.32% | Add |
| 24 | SD | Sandridge Energy Inc | 0% | — | Unchanged |
| 25 | STOK | Stoke Therapeutics Inc | 0% | -9.09% | Trim |
| 26 | SEA1EUR | Seabridge Gold Inc | 0% | +4.51% | Add |
| 27 | CRSP | CRISPR Therapeutics AG | 0% | — | Unchanged |
| 28 | NOV | Nov Inc | 0% | -20.89% | Trim |
| 29 | NE | Noble Corporation plc | 0% | -36.87% | Trim |
| 30 | RNAC | Cartesian Therapeutics Inc | — | +3.83% | Add |
| 31 | TSHA | Taysha Gene Therapies Inc | — | +10.31% | Add |
| 32 | URNM | Sprott Uranium Miners ETF | 0% | -38.93% | Trim |
| 33 | AUTL | Autolus Therapeutics PLC | 0% | +11.40% | Add |
| 34 | URGN | UroGen Pharma Ltd. | 0% | +10.95% | Add |
| 35 | BEAM | Beam Therapeutics Inc | 0% | -10.51% | Trim |
| 36 | ARQT | Arcutis Biotherapeutics Inc | -0.1% | +4.90% | Add |
| 37 | SLB | Slb LTD | -0.1% | -52.45% | Trim |
| 38 | HIMS | Hims & Hers Health Inc | -0.1% | — | Unchanged |
| 39 | ARWR | Arrowhead Pharmaceuticals In | -0.1% | -7.85% | Trim |
| 40 | BNTX | Biontech Se-adr | -0.1% | -18.92% | Trim |
| 41 | ✓ | Engene Holdings Inc | -0.1% | — | Unchanged |
| 42 | LXEO | Lexeo Therapeutics Inc | -0.1% | +6.47% | Add |
| 43 | ✓ | Proqr Therapeutics N.v. | -0.2% | +2.04% | Add |
| 44 | QURE | uniQure N.V. | -0.2% | +16.88% | Add |
| 45 | WVE | Wave Life Sciences Ltd. | -0.2% | +24.87% | Add |
| 46 | VRDN | Viridian Therapeutics Inc | -0.3% | — | Unchanged |
| 47 | COIN | Coinbase Global Inc -class A | -0.4% | — | Unchanged |
| 48 | PLTR | Palantir Technologies Inc-a | -0.5% | — | Unchanged |
| 49 | SPOT | Spotify Technology S.A. | -0.5% | -1.47% | Trim |
| 50 | BIIB | Biogen Inc | -0.7% | -40.39% | Trim |
According to official SEC Form 13F filings, Privium Fund Management B.V. reported a total U.S. public equity portfolio value of $544.2M across 60 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TSLA, SHOP, SPOT) accounted for 40.2% of total reported equity market value during Q1 2026.
Top New Position Initiated
ESPR
市值: $9.0M
Top Position Liquidated / Trimmed
MRK
前期市值: $3.9M
During Q1 2026, Privium Fund Management B.V.'s top holdings by market value included TSLA (17.2%)、SHOP (10.1%)、SPOT (6.8%). The largest single position, TSLA, represented 17.2% of total portfolio value.
In Q1 2026, Privium Fund Management B.V. made 52 total portfolio adjustments, initiating 7 new buys, adding to 24 positions, trimming 17 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.